Back
Dynatrace Vs. Regeneron Pharmaceuticals Industry Stock Comparison
Buy
56
DT
Dynatrace
Last Price:
$56.46
Seasonality Move:
1.06%
Sell
44
REGN
Regeneron Pharmaceuticals
Last Price:
$547.36
Seasonality Move:
8.46%
Sell
44
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals [REGN] share price is $547.36. The Score for REGN is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
REGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $547.36The current trend is relatively stagnant and REGN is experiencing selling pressure, which indicates risk of future bearish movement.
DT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.96 | Buy |
Relative Strength Index (14 RSI): | 63.41 | Buy |
Chaikin Money Flow: | 964372 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.85 - 55.37) | Buy |
Bollinger Bands (100): | (46.52 - 57.26) | Buy |
REGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.14 | Sell |
Relative Strength Index (14 RSI): | 56.41 | Buy |
Chaikin Money Flow: | -374814 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (493.21 - 543.01) | Buy |
Bollinger Bands (100): | (532.4 - 667.92) | Sell |
DT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.14 | Buy |
20-day SMA: | 54.77 | Buy |
50-day SMA: | 52.29 | Buy |
200-day SMA: | 53.05 | Buy |
8-day EMA: | 55.18 | Buy |
20-day EMA: | 54.58 | Buy |
50-day EMA: | 50.09 | Buy |
200-day EMA: | 26.41 | Buy |
REGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 529.95 | Buy |
20-day SMA: | 519.67 | Buy |
50-day SMA: | 552.25 | Sell |
200-day SMA: | 721.27 | Sell |
8-day EMA: | 532.93 | Buy |
20-day EMA: | 529.84 | Buy |
50-day EMA: | 551.61 | Sell |
200-day EMA: | 690.73 | Sell |
Dynatrace Earnings Growth & DT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.20 per share, and an increase next year of $0.21 per share.
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.42 per share, a decrease next quarter of $0.05 per share, a decrease this year of $9.47 per share, and an increase next year of $4.28 per share.
Dynatrace Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Regeneron Pharmaceuticals Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |